{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:12:08Z","timestamp":1786990328206,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ijbiomac.2021.01.199","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T11:51:37Z","timestamp":1612180297000},"page":"424-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Gellan gum based gastroretentive tablets for bioavailability enhancement of cilnidipine in human volunteers"],"prefix":"10.1016","volume":"174","author":[{"given":"Megha N.","family":"Karemore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil R.","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0005","doi-asserted-by":"crossref","unstructured":"J. Kitt, R. Fox, K.L. Tucker, & R.J. McManus, 2019. New approaches in hypertension management: a review of current and developing technologies and their potential impact on hypertension care. Curr. Hypertens. Reports. 21, 6. doi:https:\/\/doi.org\/10.1007\/s11906-019-0949-4.","DOI":"10.1007\/s11906-019-0949-4"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0010","unstructured":"World Health Organization. A Global Brief on Hypertension. Report. April 2013. Contract No.: WHO\/DCO\/WHD\/2013.2."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0015","doi-asserted-by":"crossref","unstructured":"J.N. Basile, Systolic blood pressure: it is time to focus on systolic hypertension-especially in older people, BMJ. 325(2002) 917\u2013918. doi:https:\/\/doi.org\/10.1136\/bmj.325.7370.917.","DOI":"10.1136\/bmj.325.7370.917"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0020","unstructured":"G.J. Tortora, S.R. Grabowiski, The cardiovascular system: Blood vessels and hemodynamics, in: Principles of Anatomy and Physiology, Tenth ed., John Wiley & Sons, New York, 2003, pp.705\u2013706."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0025","doi-asserted-by":"crossref","unstructured":"E.D. Taco-Vasquez, F. Barrera, M. Serrano-Duenas, E. Jimenez, A. Rocuts, E.R. Perez, 2019. Association between blood viscosity and cardiovascular risk factors in patients with arterial hypertension in a high altitude setting. Cureus. 11, e3925. doi:https:\/\/doi.org\/10.7759\/cureus.3925.","DOI":"10.7759\/cureus.3925"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0030","doi-asserted-by":"crossref","unstructured":"T. Celik, S. Balta, C. Ozturk, & A. Iyisoy, Whole blood viscosity and cardiovascular diseases: a forgotten old player of the game, Med. Prin. Practice. 25(2016) 499\u2013500. doi:https:\/\/doi.org\/10.1159\/000446916.","DOI":"10.1159\/000446916"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0035","unstructured":"G. Cicco, A. Pirrelli, Red Blood Cell (RBC) deformability, RBC Aggregability and tissue oxygenation in hypertension, Clin. Hemorheol. Microcirc.. 21(1999) 169\u2013177."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0040","unstructured":"H.J. Meiselman, Hemorheologic alterations in hypertension: chicken or egg? Clin. Hemorheol. Microcirc.. 2(1999) 195\u2013200."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0045","unstructured":"M. London, The role of blood rheology in regulating blood pressure, Clin. Hemorheol. Microcirc.. 17(1997) 93\u2013106."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0050","doi-asserted-by":"crossref","unstructured":"F. Zannad, J.F. Stoltz, Blood rheology in arterial hypertension, J. Hypertens. Suppl.. 10(1992) S69\u201378.","DOI":"10.1097\/00004872-199207001-00010"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0055","first-page":"633","article-title":"Blood rheology in myocardial infarction and hypertension","volume":"23","author":"Chien","year":"1986","journal-title":"Biorheology"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1081\/CEH-120005376","article-title":"Increased ability of erythrocytes to aggregate in spontaneously hypertensive rats","volume":"24","author":"Lominadze","year":"2002","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0065","doi-asserted-by":"crossref","unstructured":"P.A. James, S. Oparil, B.L. Carter, W.C. Cushman, C. Dennison-Himmelfarb, J. Handler et al., evidence-based guideline for the management of high blood pressure in adults, JAMA. 311(2014) 507\u2013520. doi:https:\/\/doi.org\/10.1001\/jama.2013.284427.","DOI":"10.1001\/jama.2013.284427"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0070","doi-asserted-by":"crossref","unstructured":"G. Mancia, R. Fagard, K. Narkiewicz et al., ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), J. Hypertens.. 31(2013) 1281\u20131357. doi:https:\/\/doi.org\/10.1097\/01.hjh.0000431740.32696.cc.","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0075","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0080","doi-asserted-by":"crossref","unstructured":"A.V. Chobanian, G.L. Bakris, H.R. Black et al., The seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report [published correction appears in JAMA. 2003 Jul 9;290(2):197], JAMA. 289(2003) 2560\u20132572. doi:https:\/\/doi.org\/10.1001\/jama.289.19.2560.","DOI":"10.1001\/jama.289.19.2560"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0085","doi-asserted-by":"crossref","unstructured":"S. Treesinchai, S. Puttipipatkhachorn, T. Pitaksuteepong, S. Sungthongjeen, Development of curcumin floating tablets based on low density foam powder, Asian J Pharm. Sci. 11(2015) 130\u2013131 doi:https:\/\/doi.org\/10.1016\/j.ajps.2015.11.092.","DOI":"10.1016\/j.ajps.2015.11.092"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0090","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-019-1391-2","article-title":"Formulation, optimization, and in vivo evaluation of gastroretentive drug delivery system of nifedipine for the treatment of preeclampsia","volume":"20","author":"Karemore","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0095","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ihj.2013.11.001","article-title":"The fourth-generation calcium channel blocker: Cilnidipine","volume":"65","author":"Chandra","year":"2013","journal-title":"Indian Heart J."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00005344-199808000-00023","article-title":"Comparison of 24-hour blood pressure, heart rate, and autonomic nerve activity in hypertensive patients treated with cilnidipine or nifedipine retard","volume":"32","author":"Minami","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0105","doi-asserted-by":"crossref","unstructured":"Y. Mori, S. Aritomi, K. Niinuma, T. Nakamura, K. Matsuura, J. Yokoyama, K. Utsunomiya, Additive effects of cilnidipine, an L-\/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka long-Evans Tokushima fatty rats with type 2 diabetes mellitus, Drug Des Devel Ther. 8(2014) 799\u2013810. doi:https:\/\/doi.org\/10.2147\/DDDT.S47441.","DOI":"10.2147\/DDDT.S47441"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0110","doi-asserted-by":"crossref","unstructured":"Q. Liu, Y. Mai, X. Gu, Y. Zhao, X. Di, X. Ma, & J. Yang, 2020. A wet-milling method for the preparation of cilnidipine nanosuspension with enhanced dissolution and oral bioavailability. J. Drug Deliv. Sci. Technol. 55, 101371. doi:https:\/\/doi.org\/10.1016\/j.jddst.2019.101371.","DOI":"10.1016\/j.jddst.2019.101371"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0115","doi-asserted-by":"crossref","unstructured":"J. Lee, H. Lee, K. Jang, K.S. Lim, D. Shin, K.S. Yu, Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers, Drug Des Devel Ther. 8(2014) 1781\u20131788 doi:https:\/\/doi.org\/10.2147\/DDDT.S68574.","DOI":"10.2147\/DDDT.S68574"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0120","unstructured":"X.Q. Liu, Y. Zhao, D. Li, Z.Y. Qian, G.J. Wang, Metabolism and metabolic inhibition of cilnidipine in human liver microsomes, Acta Pharmacol. Sin.. 24(2003) 263\u20138."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0125","doi-asserted-by":"crossref","unstructured":"K. Khatoon, Md. Rizwanullah, S. Amin, S. R. Mir, S. Akhter, 2019. Cilnidipine loaded transfersomes for transdermal application: formulation optimization, in-vitro and in vivo study. J. Drug Deliv. Sci. Technol. 54, 101303 doi:https:\/\/doi.org\/10.1016\/j.jddst.2019.101303.","DOI":"10.1016\/j.jddst.2019.101303"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0130","doi-asserted-by":"crossref","unstructured":"H. Uneyama, H. Uchida, T. Konda, and R. Yoshimoto, Cilnidipine: preclinical profile and clinical evaluation, Cardiovasc Drug Rev. 17(1999) 341\u2013357 doi:https:\/\/doi.org\/10.1111\/j.1527-3466.1999.tb00024.x.","DOI":"10.1111\/j.1527-3466.1999.tb00024.x"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0135","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1128\/aem.43.5.1086-1091.1982","article-title":"Agar-like polysaccharide produced by a Pseudomonas species: production and basic properties","volume":"43","author":"Kang","year":"1982","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0140","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0032-9592(02)00321-7","article-title":"Fermentative production of gellan using Sphingomonas paucimobilis","volume":"38","author":"Nampoothiri","year":"2003","journal-title":"Process Biochem."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0145","unstructured":"I.B. Bajaj, S.A. Survase, P.S. Saudagar, R.S. Singhal, Gellan gum: fermentative production, downstream processing and applications, food Technol. Biotechnol. 45(2007) 341\u2013354."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0008-6215(83)88361-X","article-title":"Structural studies of gellan gum, an extracellular polysaccharide elaborated by Pseudomonas elodea","volume":"124","author":"Jansson","year":"1983","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0155","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/bip.360300322","article-title":"On the physicochemical properties of gellan gum","volume":"30","author":"Milas","year":"1990","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijpharm.2014.08.044","article-title":"Evaluation of gellan gum fluid gels as modified release oral liquids","volume":"475","author":"Mahdi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0165","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.carbpol.2013.01.030","article-title":"An insight into the emerging exopolysaccharide gellan gum as a novel polymer","volume":"93","author":"Prajapati","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0170","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2014.03.038","article-title":"Application of gellan gum in pharmacy and medicine","volume":"466","author":"Osmalek","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0175","first-page":"1460","article-title":"Development and evaluation of novel immediate release tablets of metoclopramide HCl by direct compression using treated gellan gum as a disintegration-accelerating agent","volume":"2","author":"Shiyani","year":"2009","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0180","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.carbpol.2012.05.071","article-title":"Microwave assisted synthesis and characterization of acrylamide grafted gellan, application in drug delivery","volume":"90","author":"Vijan","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0185","doi-asserted-by":"crossref","unstructured":"P.I. Franklin-Ude, M.O. Emeje, S.I. Ofoefule, Evaluation of gellan gum as a mini-matrix for sustained release of ephedrine hydrochloride granules, J. Pharmacol. Toxicol. 2(2007) 646\u2013652. doi:https:\/\/doi.org\/10.3923\/jpt.2007.646.652.","DOI":"10.3923\/jpt.2007.646.652"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0190","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijbiomac.2010.05.005","article-title":"Evaluation of the fluid uptake kinetics and drug release from gellan gum tablets containing metronidazole","volume":"47","author":"Emeje","year":"2010","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0195","doi-asserted-by":"crossref","unstructured":"F.P. Gunning, E.L. Greve, A.M. Bron, J.M. Bosc, J.G. Royer, J.L. George, P. Lesure, D. Sirbat, Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in Gelrite vehicle: a multiple-dose efficacy study, Graefes Arch. Clin. Exp. Ophthalmol. 23(1993) 384\u2013388. doi:https:\/\/doi.org\/10.1007\/BF00919645.","DOI":"10.1007\/BF00919645"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0200","doi-asserted-by":"crossref","unstructured":"Y.D. Sanzgiri, S. Maschi, V. Crescenzi, L. Callegaro, E.M. Topp, V.J. Stella, Gellan-based systems for ophthalmic sustained delivery of methylprednisolone, J. Control. Release 26(1993) 195\u2013201. doi:https:\/\/doi.org\/10.1016\/0168-3659(93)90186-9.","DOI":"10.1016\/0168-3659(93)90186-9"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0205","doi-asserted-by":"crossref","unstructured":"A.K. Zimmer, P. Chetoni, M.F. Saettone, H. Zerbe, J. Kreuter, Evaluation of pilocarpine-loaded albumin particles as controled drug delivery systems for the eye II co-administration with bioadhesive and viscous polymers, J. Control. Release 33(1995) 31\u201346. doi:https:\/\/doi.org\/10.1016\/0168-3659(94)00059-4.","DOI":"10.1016\/0168-3659(94)00059-4"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0210","unstructured":"K. Kesavan, G. Nath, J.K. Pandit, Preparation and in vitro antibacterial evaluation of gatifloxacin mucoadhesive gellan system, DARU. 18(2010) 237\u2013246."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0215","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1208\/s12249-010-9413-0","article-title":"In situ gelling gelrite\/ alginate formulations as vehicles for ophthalmic drug delivery","volume":"11","author":"Liu","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2012.12.049","article-title":"Promising ionsensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits","volume":"443","author":"Tayel","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0225","doi-asserted-by":"crossref","unstructured":"B. Jansson, H. H\u00e4gerstr\u00f6m, N. Frans\u00e9n, K. Edsman, E. Bj\u00f6rk, The influence of gellan gum on the transfer of fluorescein dextran across rat nasal epithelium in vivo, Eur. J. Pharm. and Biopharm. 59(2005) 557\u2013564. doi:https:\/\/doi.org\/10.1016\/j.ejpb.2004.10.001.","DOI":"10.1016\/j.ejpb.2004.10.001"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0230","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1745-7254.2007.00540.x","article-title":"Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy","volume":"28","author":"Cao","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0235","doi-asserted-by":"crossref","unstructured":"L. Cao, W. Ren, Z. Zhang, E. Chen, F. Xu, J. Chen, L.C. Liu, X.G. Jiang, In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate, Int. J. Pharm. 365(2009) 109\u2013115. doi:https:\/\/doi.org\/10.1016\/j.ijpharm.2008.08.042.","DOI":"10.1016\/j.ijpharm.2008.08.042"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0240","doi-asserted-by":"crossref","unstructured":"H. Mahajan, H. Shaikh, S. Gattani, P. Nerkar, In situ gelling system based on thiolated gellan gum as new carrier for nasal administration of dimenhydrinate, Int. J. Pharm. Sci. Nanotechnol. 2(2009) 544\u2013550.","DOI":"10.37285\/ijpsn.2009.2.2.8"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0245","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijpharm.2016.05.062","article-title":"Development of gellan gum containing formulations for transdermal drug delivery: component evaluation and controlled drug release using temperature responsive nanogels","volume":"509","author":"Carmona-Moran","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0250","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ijbiomac.2020.06.261","article-title":"Impact of rasagiline nanoparticles on brain targeting efficiency via gellan gum based transdermal patch: a nanotheranostic perspective for parkinsonism","volume":"164","author":"Bali","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0255","doi-asserted-by":"crossref","unstructured":"A.B. Nair, J. Shah, B.A. Aljaeid, B.E. Al-Dhubiab, & S. Jacob, 2019. Gellan gum-based hydrogel for the transdermal delivery of Nebivolol: optimization and evaluation. Polymers. 11, 1699. doi:https:\/\/doi.org\/10.3390\/polym11101699.","DOI":"10.3390\/polym11101699"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0260","doi-asserted-by":"crossref","unstructured":"M.N. Karemore, J.G. Avari, In-situ gel of nifedipine for preeclampsia: Optimization, in-vitro and in-vivo evaluation, J. Drug Deliv. Sci. Technol. 50(2019) 78\u201389. doi:https:\/\/doi.org\/10.1016\/j.jddst.2019.01.025.","DOI":"10.1016\/j.jddst.2019.01.025"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0265","doi-asserted-by":"crossref","unstructured":"F.I. Boni, F.G. Prezotti & B.S. Ferreira Cury, Gellan gum microspheres crosslinked with trivalent ion: effect of polymer and crosslinker concentrations on drug release and mucoadhesive properties, Drug Dev. Ind. Pharm. 42(2015) 1\u201329. doi:https:\/\/doi.org\/10.3109\/03639045.2015.1125915.","DOI":"10.3109\/03639045.2015.1125915"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0270","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijbiomac.2012.10.033","article-title":"Evaluation of carboxymethyl gellan gum as a mucoadhesive polymer","volume":"53","author":"Ahuja","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0275","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijbiomac.2014.09.052","article-title":"Synthesis, characterization and evaluation of methacrylamide grafted gellan as sustained release tablet matrix","volume":"72","author":"Nandi","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0280","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.carbpol.2013.12.031","article-title":"Tamarind seed polysaccharide\u2013gellan mucoadhesive beads for controlled release of metformin HCl","volume":"103","author":"Nayak","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0285","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.carbpol.2015.10.054","article-title":"Gastroretentive extended release of metformin from methacrylamide-g-gellan and tamarind seed gum composite matrix","volume":"137","author":"Priyadarshini","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0290","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0378-5173(94)90236-4","article-title":"Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application","volume":"105","author":"Jim\u00e9nez-Castellanos","year":"1994","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0295","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1081\/DDC-200037179","article-title":"The macromolecular polymers for the preparation of hydrodynamically balanced systems - methods of evaluation","volume":"30","author":"Dorozy\u0144ski","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0300","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1208\/s12249-009-9210-9","article-title":"Development and in vivo floating behavior of verapamil HCl intragastric floating tablets","volume":"10","author":"Patel","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0305","doi-asserted-by":"crossref","unstructured":"T. Higuchi, Mechanism of sustained action medication, J. Pharm. Sci.. 52(1963) 1145\u20131149. doi:https:\/\/doi.org\/10.1002\/jps.2600521210.","DOI":"10.1002\/jps.2600521210"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0310","doi-asserted-by":"crossref","unstructured":"R.W. Korsmeyer, R. Gumy, E. Doelker, P. Buri, N.A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15(1983) 25\u201335. doi:https:\/\/doi.org\/10.1016\/0378-5173(83)90064-9.","DOI":"10.1016\/0378-5173(83)90064-9"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0315","doi-asserted-by":"crossref","unstructured":"B. Narasimhan, Mathematical models describing polymer dissolution : consequences for drug delivery, Adv. Drug Deliv. Rev. 48(2001) 195\u2013210. doi:https:\/\/doi.org\/10.1016\/S0169-409X(01)00117-X.","DOI":"10.1016\/S0169-409X(01)00117-X"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0320","doi-asserted-by":"crossref","unstructured":"J. Takahara, K. Takayama, T. Nagai, Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations, J. Control. Release 49(1997) 11\u201320. doi:https:\/\/doi.org\/10.1016\/S0168-3659(97)00030-8.","DOI":"10.1016\/S0168-3659(97)00030-8"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0325","doi-asserted-by":"crossref","unstructured":"K.R. Lee, Y.J. Chae, J.H. Lee, D.D. Kim, S. Chong, C.K. Shim & S.J. Chung, Quantification of Cilnidipine in human plasma by liquid chromatography-mass spectrometry, J. Liquid Chrom. Rel. Technol. 35(2012) 308\u2013320. doi:https:\/\/doi.org\/10.1080\/10826076.2011.597078.","DOI":"10.1080\/10826076.2011.597078"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0330","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.preghy.2018.06.014","article-title":"Zeta potential as a novel diagnostic tool for preeclampsia","volume":"13","author":"Karemore","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0335","unstructured":"J.T. Carstensen, Drug Stability: Principles and Practices. 2nd ed., Marcel Dekker Inc., New York, 1990."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0340","doi-asserted-by":"crossref","unstructured":"M.N. Gambhire, K.W. Ambade, S.D. Kurmi, V.J. Kadam, K.R. Jadhav, Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride, AAPS PharmSciTech. 8(2007) E1-E9. doi:https:\/\/doi.org\/10.1208\/pt0803073.","DOI":"10.1208\/pt0803073"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0345","doi-asserted-by":"crossref","unstructured":"S.D. Paul, H. Sharma, G. Jeswani, & A.K. Jha, Novel gels: implications for drug delivery, Nanostructures for Drug Delivery. (2017) 379\u2013412. doi:https:\/\/doi.org\/10.1016\/b978-0-323-46143-6.00012-9.","DOI":"10.1016\/B978-0-323-46143-6.00012-9"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0350","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201900187","article-title":"Advancement in the biomedical applications of the (nano)gel structures based on particular polysaccharides","volume":"19","author":"Chiriac","year":"2019","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0355","doi-asserted-by":"crossref","unstructured":"B. Kundu, V. Brancato, J.M. Oliveira, V.M. Correlo, R.L. Reis, S.C. Kundu, Silk fibroin promotes mineralization of gellan gum hydrogels, Int. J. Biolog. Macromol. 153(2020), 1328\u20131334. doi:https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.10.269.","DOI":"10.1016\/j.ijbiomac.2019.10.269"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0360","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/term.2675","article-title":"Mineralization of gellan gum hydrogels with calcium and magnesium carbonates by alternate soaking in solutions of calcium\/magnesium and carbonate ion solutions","volume":"12","author":"Lopez-Heredia","year":"2018","journal-title":"J. Tissue Eng. & Regen. Med"},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0365","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.carbpol.2013.11.060","article-title":"Optimization of HPMC and carbopol concentrations in non-effervescent floating tablet through factorial design","volume":"102","author":"Acharya","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0370","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejps.2005.08.005","article-title":"In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form","volume":"27","author":"Bertram","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0375","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.foodhyd.2012.01.004","article-title":"Gelation of gellan \u2013 a review","volume":"28","author":"Morris","year":"2012","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.ijbiomac.2021.01.199_bb0380","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0378-5173(96)04644-3","article-title":"Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets","volume":"142","author":"Sung","year":"1996","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021002476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021002476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:41:21Z","timestamp":1758876081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813021002476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":76,"alternative-id":["S0141813021002476"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.01.199","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gellan gum based gastroretentive tablets for bioavailability enhancement of cilnidipine in human volunteers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.01.199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}